The effect of concomitant proton pump inhibitor and cabozantinib on the outcomes of patients with metastatic renal cell carcinoma.
暂无分享,去创建一个
O. Mir | A. Paci | B. Escudier | R. Flippot | L. Albiges | A. Guida | E. Rassy | E. Auclin | E. Colomba | D. Combarel | L. Cerbone | A. Géraud | C. Alves Costa Silva | Axelle Benchimoll-Zouari